Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GLAUKOS Corp Investor Presentation 2017

Mar 10, 2017

31074_rns_2017-03-10_fc472e0f-c459-4702-8969-0efa7ed7838a.zip

Investor Presentation

Open in viewer

Opens in your device viewer

8-K 1 a17-8115_18k.htm 8-K

*UNITED STATES*

*SECURITIES AND EXCHANGE COMMISSION*

*Washington, D.C. 20549*

*FORM 8-K*

*CURRENT REPORT*

*Pursuant to Section 13 or 15(d) of the*

*Securities Exchange Act of 1934*

Date of Report (Date of earliest event reported): March 10, 2017

*GLAUKOS CORPORATION*

(Exact name of registrant as specified in its charter)

Delaware 001-37463 33-0945406
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)
229 Avenida Fabricante San Clemente, California 92672
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (949) 367-9600

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

SEQ.=1,FOLIO='',FILE='C:\JMS\C902398\17-8115-1\task8328095\8115-1-ba.htm',USER='C902398',CD='Mar 10 23:00 2017'

Item 7.01 Regulation FD Disclosure.

Glaukos Corporation (the “Company”) intends to present the materials attached as Exhibit 99.1 to this Current Report on Form 8-K (the “Investor Presentation”) from time to time in presentations to investors and other stakeholders. The Investor Presentation will also be available on the investor page of the Company’s website at http://investors.glaukos.com.

The information in this Item 7.01 (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, and is not incorporated by reference into any filing of the Company whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description
99.1 Investor Presentation, dated March 2017.

2

SEQ.=1,FOLIO='2',FILE='C:\JMS\C902398\17-8115-1\task8328095\8115-1-ba.htm',USER='C902398',CD='Mar 10 23:00 2017'

*SIGNATURES*

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

/s/ Richard L. Harrison
Name: Richard L. Harrison
Title: Chief Financial Officer

Date: March 10, 2017

3

SEQ.=1,FOLIO='3',FILE='C:\JMS\C902398\17-8115-1\task8328095\8115-1-ba.htm',USER='C902398',CD='Mar 10 23:00 2017'